Follow the latest coverage, related explainers and connected technology stories.
Crunchbase data indicates that global biotech company funding is expected to remain within the $36 billion to $40 billion range in 2026, despite artificial intelligence capturing a large share of venture capital. AI drug design and discovery companies stand out among the largest funding rounds, alongside continued public offerings and acquisition deals in the sector.